Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Neurochem. 2018 Sep 11;147(2):222–239. doi: 10.1111/jnc.14555

Fig. 3.

Fig. 3

VU0409551 treatment enhanced c-Fos expression in BACHD mice. Shown are representative immunoblots for c-Fos (upper panel) and actin (lower panel) expression in the hippocampus (a) and striatum (b) of wild-type (WT) and BACHD mice, treated with either vehicle or VU0409551. 80 μg of total cell lysate was used for each sample. Graphs show the densitometric analysis of c-Fos expression in the hippocampus (a) and striatum (b) of WT and BACHD mice, treated with either vehicle or VU0409551. Data represent the means ± SEM. Number of mice: WT-vehicle n = 6, WT-VU0409551 n = 5, BACHD-vehicle n = 6, and BACHD-VU0409551 n = 5. *indicates significant difference (p < 0.05).